These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34877503)

  • 1. Next generation Fc scaffold for multispecific antibodies.
    Estes B; Sudom A; Gong D; Whittington DA; Li V; Mohr C; Li D; Riley TP; Shi SD; Zhang J; Garces F; Wang Z
    iScience; 2021 Dec; 24(12):103447. PubMed ID: 34877503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.
    Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA
    MAbs; 2021; 13(1):1862451. PubMed ID: 33491549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.
    Iwasaki YW; Tharakaraman K; Subramanian V; Khongmanee A; Hatas A; Fleischer E; Rurak TT; Ngok-Ngam P; Tit-Oon P; Ruchirawat M; Satayavivad J; Fuangthong M; Sasisekharan R
    Front Immunol; 2022; 13():1063002. PubMed ID: 36703993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.
    Ha JH; Kim JE; Kim YS
    Front Immunol; 2016; 7():394. PubMed ID: 27766096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats.
    Fernández-Quintero ML; Quoika PK; Wedl FS; Seidler CA; Kroell KB; Loeffler JR; Pomarici ND; Hoerschinger VJ; Bujotzek A; Georges G; Kettenberger H; Liedl KR
    Front Mol Biosci; 2022; 9():812750. PubMed ID: 35155578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies.
    Dietrich S; Gross AW; Becker S; Hock B; Stadlmayr G; Rüker F; Wozniak-Knopp G
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140250. PubMed ID: 31295556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational selection of building blocks for the assembly of bispecific antibodies.
    Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F
    MAbs; 2021; 13(1):1870058. PubMed ID: 33397191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
    Skegro D; Stutz C; Ollier R; Svensson E; Wassmann P; Bourquin F; Monney T; Gn S; Blein S
    J Biol Chem; 2017 Jun; 292(23):9745-9759. PubMed ID: 28450393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient production of bispecific antibody by FAST-Ig
    Koga H; Yamano T; Betancur J; Nagatomo S; Ikeda Y; Yamaguchi K; Nabuchi Y; Sato K; Teranishi-Ikawa Y; Sato M; Hirayama H; Hayasaka A; Torizawa T; Haraya K; Sampei Z; Shiraiwa H; Kitazawa T; Igawa T; Kuramochi T
    MAbs; 2023; 15(1):2222441. PubMed ID: 37339067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
    Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
    MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
    Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
    MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering therapeutic bispecific antibodies using CrossMab technology.
    Klein C; Schaefer W; Regula JT; Dumontet C; Brinkmann U; Bacac M; Umaña P
    Methods; 2019 Feb; 154():21-31. PubMed ID: 30453028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C
    Bagert JD; Oganesyan V; Chiang CI; Iannotti M; Lin J; Yang C; Payne S; McMahon W; Edwards S; Dippel A; Hutchinson M; Huang F; Aleti V; Niu C; Qian C; Denham J; Ferreira S; Pradhan P; Penney M; Wang C; Liu W; Walseng E; Mazor Y
    MAbs; 2023; 15(1):2273449. PubMed ID: 37930310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
    Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P
    J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering bispecific antibodies with defined chain pairing.
    Krah S; Sellmann C; Rhiel L; Schröter C; Dickgiesser S; Beck J; Zielonka S; Toleikis L; Hock B; Kolmar H; Becker S
    N Biotechnol; 2017 Oct; 39(Pt B):167-173. PubMed ID: 28137467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.